Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already signal read-only, idempotent, and non-destructive behavior; the description adds substantial behavioral detail beyond that: cascading internal lookups, graceful degradation when GLEIF/OpenFIGI is unavailable, explicit `unresolved` reporting, and returning `figi_candidates` instead of asserting ambiguous matches. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with trigger phrases and the 'Use FIRST' rule, and nearly every clause adds useful semantics. However, it is a very long, dense single paragraph with many nested parentheticals; breaking it into bullets or shorter sentences would improve scannability for an agent.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite having no output schema, the description explains key return behaviors: identifiers with source labels, `figi_candidates` for ambiguous matches, explicit `unresolved` entries, and what identifiers are returned for each type. It also covers graceful degradation and input source mappings, making the tool fully actionable without external documentation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, and the description adds significant meaning beyond the schema. It explains accepted input forms for `value` (ticker, CIK, ISIN, entity name), clarifies the 'ENTITY NAME ONLY' rule with a concrete bond example, and expands the meaning of the `type` enum with source details and edge cases.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the verb and resource: resolve a user-spoken NAME to canonical/official identifiers. It gives concrete trigger phrases, distinguishes identifier lookup from general entity handling, and names the supported types ('company', 'drug'). This goes well beyond the tool title and effectively differentiates it from siblings like entity_profile.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says 'Use FIRST whenever you have a name but need an ID' and includes many natural-language examples. It provides strong positive usage context, but it does not explicitly name alternatives or state when not to use this tool, so it stops short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Many tools have overlapping purposes, especially the ask_pipeworx variants (ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded) and deep_research, which all route questions to structured data. Additionally, the server includes many prediction market and visibility tools unrelated to the 'Arxiv' name, causing confusion about which tool to use for a given query.

Naming Consistency4/5

Tool names follow a mostly consistent snake_case verb_noun pattern (e.g., search_papers, get_paper, remember, recall). A few compound names like ask_pipeworx_grounded or polymarket_arbitrage deviate slightly, but overall the naming is predictable and clear.

Tool Count1/5

33 tools is far too many for a server named 'Arxiv'. The core arXiv functionality requires only 2-3 tools (search and fetch), while the rest cover unrelated domains like prediction markets, company profiles, and data retrieval. The tool count severely mismatches the server's stated purpose.

Completeness3/5

For the actual scope (a general-purpose data retrieval platform), the tool set is broad and covers multiple domains (finance, drugs, patents, etc.). However, for the implied arXiv focus, it has basic coverage but lacks features like category listing or author-specific searches. The completeness is adequate for the broad scope but not for the server name.